The WACC of CytomX Therapeutics Inc (CTMX) is 6.6%.
| Range | Selected | |
| Cost of equity | 7.00% - 10.10% | 8.55% |
| Tax rate | 0.20% - 12.10% | 6.15% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.0% - 7.2% | 6.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.68 | 0.93 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.00% | 10.10% |
| Tax rate | 0.20% | 12.10% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.0% | 7.2% |
| Selected WACC | 6.6% | |